Skip to main content

ScienceDex / Researcher record

Cone, Richard

From the FY2021 NIH awards this investigator leads as contact PI. The department is the award's.

FY2021 NIH rank #1,445
  • Rising Star
  • Top 10% Funded

NIH Funding · FY2021

$3.3M
Full award amounts, FY2021
6
Records listing this PI
#1,445
By linked amount among FY2021 PIs
2008
ScienceDex PI coverage

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

Linked awards ($M)Award-linked rank
View yearly values
Award-linked funding and rank by fiscal year
Fiscal yearLinked awardsRecordsRank
2008$262,2351#26,483
2009$216,1531#32,793
2018$887,7044#8,776
2019$449,6892#21,234
2020$999,0321#2,932
2021$3,289,9796#1,445
2022$1,930,7072#3,858
2023$2,064,9292#3,582

Award activity

Awards through the years

NIH award records listing this researcher in each fiscal year.

  1. FY20081 record
  2. FY20091 record
  3. FY20184 records
  4. FY20192 records
  5. FY20201 record
  6. FY2021 · selected6 records
  7. FY20222 records
  8. FY20232 records

Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Cone, Richard. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2021 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets About this stat →

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Publications

Loading publications…

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2008 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

FY2021 award records by amount

NIH award records listing Cone, Richard as a PI. Multi-PI records show the full award amount for context.

  • 5R44AI138728-03R44Contact PI
    In vivo dose finding for IN-002 in neonatal lambs for inhaled immunotherapy of RSV
    $995.7K
    award amount
  • 5R44HD100231-02R44Contact PI
    In vivo dose finding for an antibody based nonhormonal contraceptive intravaginal ring
    $757K
    award amount
  • 4R44AI141054-02R44Contact PI
    Development of RespiraClear for targeted mucosal treatment of RSV infections
    $658.4K
    award amount
  • 1R44AI157661-01R44Contact PI
    SBIR: In vivo validation and IND-enabling development of MM004, a bispecific inhaled immunotherapy for RSV and MPV
    $306.5K
    award amount
  • 1R43AI157652-01R43Contact PI
    Vaginal ring for sustained release of lactic acid to prevent bacterial vaginosis and associated health risks
    $306.5K
    award amount
  • 1R43HD105277-01R43Contact PI
    Multipurpose vaginal ring for non-hormonal contraception and preventing bacterial vaginosis
    $266K
    award amount

Award organization

Organizations that administered FY2021 awards listing Cone, Richard as a PI.

FY2021 award administered by Mucommune, LLC (NC).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2008
    First NIH Award
    Mucommune, LLC
  2. 2018
    $500K Cumulative Funding
  3. 2018
    $1M Cumulative Funding
  4. 2018
    Entered Top 50% Nationally
    Ranked #8776
  5. 2020
    $2M Cumulative Funding
  6. 2020
    Entered Top 25% Nationally
    Ranked #2932
  7. 2021
    $5M Cumulative Funding
  8. 2021
    Entered Top 10% Nationally
    Ranked #1445
  9. 2023
    $10M Cumulative Funding